(Q44489283)

3 December 2017

Factors associated with drug-induced visual hallucinations in Parkinson's disease (English)

1 reference

3 December 2017

1 reference

1 reference

2

Andreas A Argyriou

1 reference

3 December 2017

Spiridon Papapetropoulos

series ordinal

1

1 reference

PubMed ID

15834642

3 December 2017

John Ellul

series ordinal

3

1 reference

3 December 2017

18 April 2005

1 reference

3 December 2017

1 reference

3 December 2017

252

1 reference

3 December 2017

10

1 reference

3 December 2017

1223-1228

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-005-0840-x

3 December 2017

0 references

cites work

Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

Risk factors for nursing home placement in advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

Early dopaminergic drug-induced hallucinations in parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

Visual hallucinations in a geriatric psychiatry clinic: prevalence and associated diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

Levodopa-induced psychosis: a kindling phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

Psychotic symptoms in Parkinson's disease patients with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

Visual hallucinations associated with Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

Visual loss in Alzheimer's disease: out of sight, out of mind.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-005-0840-X

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

12 December 2020

Parkinsonism: onset, progression, and mortality

1 reference

12 December 2020

Psychosis in Dementia With Lewy Bodies

1 reference

12 December 2020

A reality test: How well do we understand psychosis in Parkinson's disease?

1 reference

12 December 2020

Parkinson's disease and dementia with Lewy bodies: one disease or two?

1 reference

12 December 2020

A preliminary investigation of laterality in Parkinson's disease and susceptibility to psychosis

1 reference

12 December 2020

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

1 reference

12 December 2020

Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.

1 reference

12 December 2020

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.

1 reference

12 December 2020

Auditory hallucinations in Parkinson's disease

1 reference

12 December 2020

Dementia with Lewy bodies

1 reference

12 December 2020

A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia.

1 reference

12 December 2020

1 reference

12 December 2020

Evidence of a Monoaminergic-Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia

1 reference

12 December 2020

Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group.

1 reference

12 December 2020

Dopaminomimetic psychosis in Parkinson's disease patients: diagnosis and treatment.

1 reference

12 December 2020

Prospective study of hallucinations and delusions in Parkinson's disease

1 reference

12 December 2020

Visual hallucinations in Parkinson's disease: a review and phenomenological survey

1 reference

12 December 2020

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

12 December 2020

Hallucinosis in idiopathic Parkinson's disease

1 reference

12 December 2020

Living with a person who has Parkinson's disease: the spouse's perspective by stage of disease. Parkinson's Study Group

1 reference

12 December 2020

10.1007/S00415-005-0840-X

Identifiers

DOI

1 reference

3 December 2017

1 reference

PubMed ID

15834642